Heim2096 • HKG
add
Simcere Pharmaceutical Group Ltd
Við síðustu lokun
8,76 $
Dagbil
8,68 $ - 9,11 $
Árabil
5,08 $ - 9,11 $
Markaðsvirði
22,55 ma. HKD
Meðalmagn
7,58 m.
V/H-hlutf.
29,21
A/V-hlutfall
1,89%
Aðalkauphöll
HKG
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CNY) | des. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 1,76 ma. | 9,08% |
Rekstrarkostnaður | 1,15 ma. | 11,53% |
Nettótekjur | 138,28 m. | 117,73% |
Hagnaðarhlutfall | 7,85 | 116,25% |
Hagnaður á hvern hlut | — | — |
EBITDA | 330,12 m. | 44,43% |
Virkt skatthlutfall | 14,95% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CNY) | des. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,94 ma. | -3,73% |
Heildareignir | 11,51 ma. | 6,05% |
Heildarskuldir | 4,44 ma. | 22,33% |
Eigið fé alls | 7,07 ma. | — |
Útistandandi hlutabréf | 2,47 ma. | — |
Eiginfjárgengi | 3,06 | — |
Arðsemi eigna | 6,01% | — |
Ávöxtun eigin fjár | 8,35% | — |
Peningaflæði
Breyting á handbæru fé
| (CNY) | des. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 138,28 m. | 117,73% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The Company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
Framkvæmdastjóri
Stofnsett
1995
Höfuðstöðvar
Vefsvæði
Starfsfólk
6.584
